InsidersTradesSigma
Track the 安科生物 stock price and the full management transaction log of the company, a publicly traded company based in China. Shares trade on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 安科生物 has recorded 3 insider filings. Market capitalisation: €13.8bn. The latest transaction was filed on 30 May 2023 (Purchase). Among the most active insiders: 周源源. Every trade is free.
3
Insider Decl.
n/a
Thresholds
€374,633
2 ops.
Buy Volume
€338,545
1 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 3,210 of 29,063 companies
72.9
score / 100
Value58
Quality88
FCF yld5.3%
Earn yld5.3%
EV/EBITDA14.4x
ROE15%
Gross mgn76%
Net mgn28%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 30 May 2023
关于 安科生物
安科生物是一家专注于医疗保健和制药领域的公司，专门从事生物制药产品的开发。该公司在XSHE市场上市。